According to a new report by Polaris Market Research, the global organ preservation market was valued at USD 230.89 million in 2021 and is projected to reach USD 410.24 million by 2030, expanding at a CAGR of 6.8% over the forecast period. Growth is underpinned by rising organ transplantation demand, expanding machine perfusion technology adoption, and accelerating healthcare infrastructure investment across key end-use industries.

What Is Driving Organ Preservation Market Growth?

Demand is climbing as the rising global burden of chronic kidney disease and sepsis-driven organ failure converges with sustained government investment in transplant-ready healthcare infrastructure. Hospitals and transplant centers are prioritizing advanced perfusion and cold-chain solutions, pushing organ preservation adoption across North America, Europe, and Asia Pacific. Polaris analysts note that the growing number of testing laboratories shortening donor-recipient cross-matching timelines positions the kidney preservation segment for sustained growth through 2030, with organ transplant centers emerging as the largest revenue contributor and machine perfusion technologies posting the fastest incremental gains.

Key Trends Shaping the Organ Preservation Industry

Machine Perfusion and Next-Gen Preservation Technology

Hypothermic and normothermic machine perfusion systems are steadily displacing static storage in high-acuity transplant settings, improving graft oxygenation and extending viable preservation windows. Persufflation techniques are also gaining traction as a low-cost way to improve organ survival before transplantation, reflecting the sector's broader technology advancement trajectory.

Healthcare Infrastructure and Regulatory Investment

Governments are expanding hospital networks and diagnostic testing capacity to identify suitable donors faster; India's Brihanmumbai Municipal Corporation, for example, has committed roughly USD 924 million to expand health centers and diagnostic services. These infrastructure and regulatory landscape shifts are widening the donor pool available to organ preservation providers.

Competitive Investment and Portfolio Expansion

Preservation-solution developers are broadening national logistics networks and validating next-generation platforms. TransMedics expanded its National OCS Program into additional U.S. states in March 2025, while BioLife Solutions launched an upgraded HypoThermosol FRS formulation in May 2024, signaling an active market outlook for cold-chain innovation.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/organ-preservation-market 

Market Segmentation: Breaking Down the Organ Preservation Market

Polaris segments the organ preservation market by solution, technique, end-user, organ type, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Solution

University of Wisconsin Solution (UW Solution) remains the most established preservation chemistry, with Custodial HTK and Perfadex serving specialized transplant protocols. Continued formulation refinement across these categories underpins reliable graft viability during transport, supporting steady demand from organ transplant centers worldwide.

By Technique

The static cold storage segment held the largest share of the organ preservation market, owing to its cost-effectiveness, simplicity, and broad applicability across transplant centers. Hypothermic and normothermic machine perfusion techniques are projected to expand at the fastest pace through 2030 as centers seek higher organ viability and expanded use of marginal donor organs.

By End-User

Organ transplant centers and hospitals collectively account for the bulk of preservation-solution consumption, reflecting the concentration of transplantation procedures in specialized surgical settings. Specialty clinics are an emerging channel as decentralized transplant-support services expand.

By Organ Type

The kidney segment is the most significant revenue contributor, driven by rising kidney transplant volumes and awareness campaigns such as the 'Advancing American Kidney Health' initiative. Liver, heart, lung, and pancreas preservation round out demand, tracking closely with chronic disease prevalence and donor availability.

Regional Outlook: Where Is Organ Preservation Growing Fastest?

North America held the largest revenue share in the organ preservation market, supported by rising FDA approvals — including TransMedics' OCS Heart System pre-market approval — and a high prevalence of chronic kidney disease affecting an estimated 37 million U.S. adults. Within North America, the U.S. remains the largest single market. Asia Pacific is expected to post the fastest CAGR through 2030, driven by rising healthcare expenditure, growing patient awareness, and expanding manufacturing footprints; Institut Georges Lopez's 2021 organ-preservation solution production facility in Tamil Nadu, India, illustrates this regional buildout. Europe rounds out the top three, supported by established transplant infrastructure across France, Germany, and the UK.

Competitive Landscape: Leading Organ Preservation Companies

Key players profiled in the report include Bridge to Life Limited, Avionord, Carnamedica, Dr. Franz Kohler, Shanghai Genext, Transplant Biomedicals, Global Transplant Solutions, Essential Pharmaceuticals, Institut Georges Lopez, OrganOx Limited, Preservation Solutions, and Vascular Perfusion Solutions, who are focusing on product validation, regional program expansion, and technology partnerships to strengthen market position across the static cold storage and organ transplant centers segments outlined above. Recent moves include Shanghai Genext Medical Technology's 2024 collaboration with a Southeast Asian transplant hospital to pilot its kidney perfusion system, and X-Therma's completion of preclinical studies for its XT-ViVo preservation platform, both aimed at improving organ viability during prolonged storage, both aimed at deepening share in North America and Asia Pacific.

Why It Matters for Buyers Evaluating Organ Preservation Solutions

For stakeholders researching buyers evaluating organ preservation solutions, this report benchmarks organ preservation market share, segment-level data, and forecast trends — by type, application, end-use, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking adjacent segments as a growth opportunity.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Xerostomia Therapeutics Market

U.S. Sports Betting Market

Fire Protection System Market

Morocco Bus Market

Agricultural Tractors Market

Agricultural Tractors Market

Omega 3 Market

Metastatic Lung Adenocarcinoma Treatment Market

Viral Sensitizers Market